Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NBP145707

anti-GRO2, Polyclonal, Novus Biologicals™
SDP

Catalog No. NBP145707 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP145707 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP145707 Supplier Novus Biologicals Supplier No. NBP145707

Specifications

Antigen GRO2
Applications Western Blot, ELISA, Neutralization
Classification Polyclonal
Concentration 0.5 mg/mL
Conjugate Unconjugated
Dilution Western Blot, ELISA, Neutralization
Formulation PBS (pH 7.2), 1.0% BSA and 50% Glycerol with 0.02% Thimerosal
Gene Accession No. P10889
Gene Alias chemokine (C-X-C motif) ligand 2, CINC-2a, GRO2 oncogene, GRO2MIP2, GROb, gro-beta, Growth-regulated protein beta, Macrophage inflammatory protein 2-alpha, melanoma growth stimulatory activity beta, MGSA beta, MGSA-b, MIP-2a, MIP2AC-X-C motif chemokine 2, SCYB2MIP2-alpha
Gene Symbols CXCL2
Host Species Rabbit
Immunogen E. coli-expressed recombinant mouse MIP-2.
Purification Method Affinity Purified
Quantity 0.1 mg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 2920
Target Species Mouse
Content And Storage Store at -20C. Avoid freeze-thaw cycles.
Isotype IgG
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.